1. Valencia, Tania, Joseph, Ajay, Kachroo, Naveen, Meakin, Susan, Gnanapragasam, Vincent J. 2011. Role and expression of FRS2 and FRS3 in prostate cancer. In BMC cancer, 11, 484. doi:10.1186/1471-2407-11-484. https://pubmed.ncbi.nlm.nih.gov/22078327/
2. Hryciw, Todd, MacDonald, James I S, Phillips, Renée, Pasternak, Stephen, Meakin, Susan O. 2009. The fibroblast growth factor receptor substrate 3 adapter is a developmentally regulated microtubule-associated protein expressed in migrating and differentiated neurons. In Journal of neurochemistry, 112, 924-39. doi:10.1111/j.1471-4159.2009.06503.x. https://pubmed.ncbi.nlm.nih.gov/19943849/
3. Ranzi, Valeria, Meakin, Susan O, Miranda, Claudia, Pierotti, Marco A, Greco, Angela. . The signaling adapters fibroblast growth factor receptor substrate 2 and 3 are activated by the thyroid TRK oncoproteins. In Endocrinology, 144, 922-8. doi:. https://pubmed.ncbi.nlm.nih.gov/12586769/
4. Huang, L, Watanabe, M, Chikamori, M, Gotoh, N, Tsuchida, N. 2006. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways. In Oncogene, 25, 6457-66. doi:. https://pubmed.ncbi.nlm.nih.gov/16702953/
5. Jonsdottir, Andrea B, Sveinbjornsson, Gardar, Thorolfsdottir, Rosa B, Sulem, Patrick, Stefansson, Kari. 2025. Missense variants in FRS3 affect body mass index in populations of diverse ancestries. In Nature communications, 16, 2694. doi:10.1038/s41467-025-57753-2. https://pubmed.ncbi.nlm.nih.gov/40133257/
6. Karimpour, Mina, Totonchi, Mehdi, Behmanesh, Mehrdad, Montazeri, Hesam. 2023. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens. In Life science alliance, 7, . doi:10.26508/lsa.202302268. https://pubmed.ncbi.nlm.nih.gov/37863651/
智鼠故事 
